Item 14
approved contractSep 25, 2024
Description
Authorize to amend an existing contract with Abbott Laboratories, Inc., Columbus, OH (originally approved by G&C on 6/30/21, Item #50), to receive rebates on select formulas purchased with food instruments issued by the Special Supplemental Nutrition Program for Women, Infants and Children, at no cost to the Department, by exercising a contract renewal option, with an increase to projected rebate revenue of $5,852,414 from $8,778,621 to $14,631,035 and extending the completion date from September 30, 2024 to September 30, 2026. Effective October 1, 2024, upon G&C approval. 100% Other Revenue received from Abbott Laboratories, Inc.
Amount
$14.6M
$5,852,414, $8,778,621, $14,631,035
Funding Source
100% Other Revenue received from Abbott Laboratories
Effective Dates
September 30, 2024 — September 30, 2026
Vote Record
approved
Motion by Stevens, seconded by Warmington acted as
Joseph Kenney
(R)
yes
Cinde Warmington
(D)
yes
Janet Stevens
(R)
yes
Ted Gatsas
(R)
yes
Dave Wheeler
(R)
yes
Documents (1)
Item_14.pdf
Open in new tab →